Needles No More

Tribute to Alfred Mann

Tribute to Alfred Mann

Please find below the official statement by Mannkind Corporation. MannKind Corporation today reported with deep sadness the passing of Alfred E. Mann, age 90, the company’s Chairman Emeritus. Mr. Mann was the Chairman of...

Mannkind Corp on Facebook

Mannkind Corp on Facebook

Mannkind Corp is now active on Facebook. Get the latest news from the company and feel free to ask your own questions! Mannkind Corp is now a very transparent business.

The Mannkind Saga

The Mannkind Saga

The Martin Shreli letter From this article: “It was January 2011 when the FDA was scheduled to make its first yea-or-nay ruling on Afrezza. The first Phase 3 trials looked as encouraging then as...

MNKD on StockTwits

$MNKD on StockTwits

StockTwits is a social media platform for sharing ideas between investors. $MNKD is one of the most active stock on StockTwits. Here are the latest messages: StockTwits

VDEX Diabetes Care Centers

Afrezza and VDEX Diabetes Care Centers

  For many people, Afrezza is a life changer in the treatment of diabetes. Unfortunately, getting Afrezza is not as easy as it seems. VDEX Diabetes Care Centers might be the solution for many of...

MNKD stock chart

MNKD charts

Here is the Mannkind Corporation (MNKD) daily chart. Always fun to watch! Not too much into trading but looking for a long-term investment? This chart my be more useful

Who is Receptor Life Sciences (RLS) ?

Who is Receptor Life Sciences?

Mannkind Corporation has signed a collaboration and license agreement with Receptor Life Sciences, Inc. to develop multiple inhaled therapeutic products for conditions that like chronic pain, neurologic diseases, and inflammatory disorders. As per terms of...

Mannkind Corp (MNKD) latest SEC filings

Latest MNKD SEC Filings

Here you’ll find links to a complete list of MNKD SEC filings. These filings are registration statements, formal and periodic reports and other forms that are provided to the U.S. Securities and Exchange Commission (SEC).

Afrezza - The new inhaled insulin

All you need to know about Afrezza

Afrezza is a rapid-acting form of human insulin that is inhaled through the mouth. Afrezza is used to treat type 1 or type 2 diabetes in adults. If you have type 1 diabetes, you...

Afrezza user reviews

Afrezza reviews

Afrezza is a rapid-acting form of human insulin that is inhaled through the mouth. Afrezza is used to treat type 1 or type 2 diabetes in adults. It is available in the United States since...

Afrezza script counts

Script count

Using our own estimates derived from Symphony and IMS data, we provide Afrezza script count on a weekly basis.

Afrezza coverage

Insurance coverage

Insurance coverage is probably the most critical problem that must be addressed by Mannkind Corporation. Patients are clear about the product: Afrezza is great! The problem is not with the product but with its...

These people are bullish MNKD

These guys are bullish MNKD

Alfred Mann (Mannkind founder, largest stock holder and CEO) It is hard to imagine one of the world’s richest men, Alfred Mann, growing up poor. This entrepreneur’s first business consisted of selling magazines and...

These people are bearish MNKD

These guys are bearish MNKD

Martin Shkreli Martin Shkreli is an American hedge fund manager and entrepreneur, specializing in healthcare businesses, and is a co-founder of MSMB Capital Management and the founder of Turing Pharmaceuticals AG. He is a...

@castagna2011 on Twitter

Afrezza on Twitter

You want to get a sense of what is going on in the real world? Follow #Afrezza and read experiences from real users. You’ll fall from your chair when you realize how great some...

@castagna2011 on Twitter

$MNKD on Twitter

MNKD is one of the most interesting stocks to follow in the stock market. Reading tweets about MNKD can also be very entertaining. Watch out for trolls! Tweets about $MNKD